Aging theories of primary osteoarthritis: From epidemiology to molecular biology

被引:104
作者
Aigner, T
Rose, J
Martin, J
Buckwalter, J
机构
[1] Univ Erlangen Nurnberg, Dept Pathol, Osteoarticular & Arthrit Res Grp, D-91054 Erlangen, Germany
[2] Univ Iowa, Coll Med, Dept Orthopaed, Iowa City, IA USA
关键词
D O I
10.1089/1549168041552964
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Osteoarthritis is the most common disabling condition of humans in the western world. It has been known for a very long time that aging is the most prominent risk factor for the initiation and progression of the disease, but the explanations for this phenomenon have changed over time. The most longstanding theory is that osteoarthritis develops because of continuous mechanical wear and tear. However, osteoarthritis can also be the result of time/age-related modifications to cartilage matrix components. One of the simplest biological explanations for the initiation and progression of osteoarthritic cartilage degeneration is a mere loss of viable cells, due to apoptosis or other mechanisms. Overall, the most likely scenario is that the cells and the matrix of articular cartilage get older over time, and eventually the tissue enters a senescence-like state that makes it more prone to enter the osteoarthritic degeneration pathway. Thus, patients with osteoarthritis might progress more quickly to the senescence phenotype compared to others. Moreover, stressful conditions associated with the osteoarthritic disease process might further promote chondrocyte senescence. Primary osteoarthritis in this model would be a "premature" degeneration of the joint due to a premature chondrocyte senescence. By analogy to neurodegenerative disorders, one could refer to osteoarthritis as the "M. Alzheimer" of articular cartilage. One of the most important implications of this hypothesis is that it points to issues of cellular degeneration as the basis for understanding the initiation and progression of osteoarthritis. Equally important, it emphasizes that whatever treatment we envisage for osteoarthritis, we must take into account that we are dealing with aged/(pre) senescent cells that no longer have the ability of their juvenile counterparts to counteract the many mechanical, inflammatory, and/or other assaults to the tissue.
引用
收藏
页码:134 / 145
页数:12
相关论文
共 78 条
  • [61] MITROVIC D, 1983, LAB INVEST, V49, P309
  • [62] Clusterin/apolipoprotein J is a novel biomarker of cellular senescence that does not affect the proliferative capacity of human diploid fibroblasts
    Petropoulou, C
    Trougakos, IP
    Kolettas, E
    Toussaint, O
    Gonos, ES
    [J]. FEBS LETTERS, 2001, 509 (02) : 287 - 297
  • [63] Praemer A., 1999, MUSCULOSKELETAL COND
  • [64] The role of chondrocyte senescence in osteoarthritis
    Price, JS
    Waters, JG
    Darrah, C
    Pennington, C
    Edwards, DR
    Donell, ST
    Clark, IM
    [J]. AGING CELL, 2002, 1 (01) : 57 - 65
  • [65] MECHANICAL DETERMINANTS OF OSTEOARTHROSIS
    RADIN, EL
    BURR, DB
    CATERSON, B
    FYHRIE, D
    BROWN, TD
    BOYD, RD
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1991, 21 (03) : 12 - 21
  • [66] Chondroptosis: A variant of apoptotic cell death in chondrocytes?
    Roach, HI
    Aigner, T
    Kouri, JB
    [J]. APOPTOSIS, 2004, 9 (03) : 265 - 277
  • [67] Rothwell A G, 1973, J Bone Joint Surg Br, V55, P588
  • [68] Articular cartilage and changes in arthritis - An introduction: Cell biology of osteoarthritis
    Sandell, LJ
    Aigner, T
    [J]. ARTHRITIS RESEARCH, 2001, 3 (02) : 107 - 113
  • [69] OXYGEN AND THE CONNECTIVE TISSUES
    SCOTT, JE
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1992, 17 (09) : 340 - 343
  • [70] Is β-galactosidase staining a marker of senescence in vitro and in vivo?
    Severino, J
    Allen, RG
    Balin, S
    Balin, A
    Cristofalo, VJ
    [J]. EXPERIMENTAL CELL RESEARCH, 2000, 257 (01) : 162 - 171